Applied StemCell Picks Up $19M For Gene Editing Efforts
Milpitas-based Applied StemCell, which is developing gene editing technology and tools based on stem cell technology, has raised $19M in a Series D funding round. The company said earlier this week that the Series D investment was led by HerMed Capital, and included Ping An Ventures, Vi-Ventures and BioSciKin. The company is initially focusing its efforts on monogenic blood disorders. Applied StemCell is led by Ruhong Jiang, Ph.D.
posted on Friday, June 10, 2016 (Link to more information)
Related companies:
Applied Analysis Inc.
Related stories:
> Inscripta Raises $55.5M For Gene Editing Tools
> Sangamo Therapeutics Acquires TxCell
> Applied Materials Taps SunPower For Solar Install
> Photobucket Taps FotoFlexer For Image Editing
> VSCO Sees $40M For Photo Editing Tools
silicontap.com Home